CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824151574
- Phone
- (877) 742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- 4 Open-market sale 10% owner sold 3,703,703 shares at $8.10 ($29,999,994)
- 4 Open-market sale CFO and CBO sold 6,307 shares at $7.75 ($48,900)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CFO and CBO sold 2,127 shares at $7.24 ($15,403)
- 4 Open-market buy Director bought 7,500 shares at an average $7.81 ($58,580)
- 4 Open-market sale CFO and CBO sold 12,492 shares at an average $8.88 ($110,871)
- 4 Grant or award Chief Operating Officer acquired 32,500 shares (grant or award)
- 4 Grant or award President and Chief Executive acquired 37,500 shares (grant or award)
- 4/A Grant or award CFO and CBO acquired 25,000 shares (grant or award)
- 4 Grant or award CFO and CBO acquired 25,000 shares (grant or award)
- 4 Grant or award President and Chief Executive acquired 200,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 110,000 shares (grant or award)
- 4 Grant or award Director acquired 15,000 shares (grant or award)
- 4 Planned sale CFO and CBO sold 1,960 shares at $11.41 ($22,368)
- 4 Grant or award Director acquired 9,000 shares (grant or award)
- 4 Grant or award Director acquired 9,000 shares (grant or award)
- 4 Grant or award Director acquired 9,000 shares (grant or award)
- 4 Grant or award Director acquired 9,000 shares (grant or award)
- 4 Grant or award Director acquired 9,000 shares (grant or award)
Page 5 of 12 · 224 filings